Author

Marianne Gillard

The University of QueenslandORCID 0000-0002-2233-9975Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Organism:non-human primate· 1 Assay:proteomics· 1

Frequent Co-Authors

Adam K. WheatleyiD· 1 shared Andrew P. KellyiD· 1 shared Benjamin S. HughesiD· 1 shared Courtney E. McAleeseiD· 1 shared Hannah G. KellyiD· 1 shared Hyon‐Xhi TaniD· 1 shared Isaac Michael Barber-AxthelmiD· 1 shared James P. CooneyiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Adam K. WheatleyORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A novel chimeric coronavirus spike vaccine combining SARS-CoV-2 RBD and scaffold domains from HKU-1 elicits potent neutralising antibody responses

Veronica P. Zoest, Wen Shi Lee, Lydia Murdiyarso, Lauren Burmas, Phillip Pymm, Robyn Esterbauer, Andrew P. Kelly, Hannah G. Kelly, Isaac Michael Barber-Axthelm, James P. Cooney, Kathryn C. Davidson, Merle Dayton, Courtney E. McAleese, Marianne Gillard, Karen Hughes, , Hyon‐Xhi Tan

A chimeric coronavirus spike vaccine combining SARS-CoV-2 RBD and HKU-1 scaffold domains elicits potent neutralising antibodies and CD4 T cell help in mice and macaques.

npj Vaccines · Nov 28, 2025Peer-reviewedImmunology